Codexis Inc (CDXS)
2.735
+0.04
(+1.67%)
USD |
NASDAQ |
Apr 16, 14:23
Codexis Total Assets (Quarterly): 136.56M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 136.56M |
| September 30, 2023 | 154.46M |
| June 30, 2023 | 206.76M |
| March 31, 2023 | 218.07M |
| December 31, 2022 | 250.39M |
| September 30, 2022 | 235.29M |
| June 30, 2022 | 234.97M |
| March 31, 2022 | 235.27M |
| December 31, 2021 | 246.38M |
| September 30, 2021 | 227.55M |
| June 30, 2021 | 212.31M |
| March 31, 2021 | 212.17M |
| December 31, 2020 | 221.65M |
| September 30, 2020 | 138.02M |
| June 30, 2020 | 141.78M |
| March 31, 2020 | 149.47M |
| December 31, 2019 | 149.07M |
| September 30, 2019 | 146.20M |
| June 30, 2019 | 146.79M |
| March 31, 2019 | 101.12M |
| December 31, 2018 | 79.28M |
| September 30, 2018 | 78.60M |
| June 30, 2018 | 75.96M |
| March 31, 2018 | 44.51M |
| December 31, 2017 | 53.62M |
| Date | Value |
|---|---|
| September 30, 2017 | 44.10M |
| June 30, 2017 | 49.78M |
| March 31, 2017 | 30.63M |
| December 31, 2016 | 35.65M |
| September 30, 2016 | 38.51M |
| June 30, 2016 | 36.86M |
| March 31, 2016 | 39.19M |
| December 31, 2015 | 44.65M |
| September 30, 2015 | 44.34M |
| June 30, 2015 | 35.29M |
| March 31, 2015 | 41.42M |
| December 31, 2014 | 48.12M |
| September 30, 2014 | 44.79M |
| June 30, 2014 | 45.24M |
| March 31, 2014 | 55.96M |
| December 31, 2013 | 58.84M |
| September 30, 2013 | 66.44M |
| June 30, 2013 | 75.61M |
| March 31, 2013 | 93.64M |
| December 31, 2012 | 99.96M |
| September 30, 2012 | 119.04M |
| June 30, 2012 | 117.67M |
| March 31, 2012 | 134.60M |
| December 31, 2011 | 135.92M |
| September 30, 2011 | 144.62M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
136.56M
Minimum
Dec 2023
250.39M
Maximum
Dec 2022
192.80M
Average
212.17M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | 5.736M |
| Sutro Biopharma Inc | 470.74M |
| Avidity Biosciences Inc | 628.56M |
| Taysha Gene Therapies Inc | 172.73M |
| Janux Therapeutics Inc | 380.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.95M |
| Shareholders Equity (Quarterly) | 86.62M |
| Current Ratio | 2.609 |